The survey on the updated Post PQ Change Request process and PQDx 121 guidance shows that manufacturers are broadly satisfied with recent improvements to the system.
WHOAPI-429 (tenofovir disoproxil fumarate) manufactured by Styrax Pharma Pvt Ltd has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
A Position Note on Accessories has been published by the Assessment of Medical Devices Team.
New WHO Public Inspection Reports (WHOPIRs) were published today:
On 11 February 2026 WHO published an amended invitation to manufacturers of Monkeypox virus IVDs
New WHO Public Inspection Reports (WHOPIRs) were published today:
WHO is pleased to announce that the Prequalification of IVDs programme scope has been expanded to the following types of products: